Advanced BioMedical Technologies Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ABMT research report →
Price Chart
About the company
Advanced Biomedical Technologies, Inc. , a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures.
- CEO
- Hui Wang
- IPO
- 2008
- Employees
- 17
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on ABMT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $50.00K
- P/E
- -0.07
- PEG
- -0.00
- P/S
- 0.18
- P/B
- -0.00
- EV/EBITDA
- -41.30
- Div Yield
- 0.00%
- Gross Margin
- 81.88%
- Op Margin
- -66.38%
- Net Margin
- -190.22%
- ROE
- 6.32%
- ROIC
- 15.99%
Latest fiscal year · YoY change
- Revenue
- $270.99K+58.3%
- Gross Profit
- $221.88K+137.8%
- Op Income
- $-179,880
- Net Income
- $-515,485+29.3%
- EPS
- $-0.01+29.8%
- OCF Growth
- +13.1%
- FCF Growth
- +18.1%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.14
- RSI (14)
- 97
- Avg Volume
- 80
No earnings-call transcripts are available for ABMT yet.
- Free Float
- 99.0%
- Shares Outstanding
- 100.00M
- Float Shares
- 98.96M
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 26, 21 | Advanced Biomedical Technologies Inc. | other | 100,000 |
| Oct 26, 21 | Advanced Biomedical Technologies Inc. | other | 200,000 |
| Sep 23, 21 | Advanced Biomedical Technologies Inc. | other | 80,000 |
| Oct 30, 19 | Advanced Biomedical Technologies Inc. | other | 100,000 |
| Oct 30, 20 | Advanced Biomedical Technologies Inc. | other | 150,000 |
| Mar 9, 20 | Advanced Biomedical Technologies Inc. | other | 0 |
| Oct 30, 19 | Advanced Biomedical Technologies Inc. | other | 100,000 |
| Oct 30, 19 | Advanced Biomedical Technologies Inc. | other | 150,000 |
| Oct 23, 18 | Advanced Biomedical Technologies Inc. | other | 100,000 |
| Oct 23, 18 | Advanced Biomedical Technologies Inc. | other | 150,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ABMT coverage
Recent articles, reports, and earnings notes.
No research on ABMT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ABMT report →NeuroPace (NASDAQ:NPCE) & Advanced Biomedical Technologies (OTCMKTS:ABMT) Head to Head Survey
defenseworld.net · Apr 24
Comparing Advanced Biomedical Technologies (OTCMKTS:ABMT) and Veracyte (NASDAQ:VCYT)
defenseworld.net · Apr 6
Reviewing Advanced Biomedical Technologies (OTCMKTS:ABMT) and Rapid Micro Biosystems (NASDAQ:RPID)
defenseworld.net · Dec 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.